Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-002536-13Phase 3Completed
Phase 3, randomised trial in alcoholic hepatitis (AH) comparing Corticosteroids alone with Corticosteroids + Augmentin (2 arms). Primary endpoint: 2-month survival rate. Started Jun 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-002536-13.